Skip to main content
Top
Published in: Hepatology International 2/2022

Open Access 01-04-2022 | Correction

Correction to: Consensus on the secondary prevention of primary liver cancer

Authors: Yuemin Nan, Xiaoyuan Xu, Yanhang Gao, Rongqi Wang, Wengang Li, Ming Yang, Lingdi Liu, Zhongping Duan, Jidong Jia, Lai Wei, Hui Zhuang, Chinese Society of Hepatology, Chinese Medical Association

Published in: Hepatology International | Issue 2/2022

Login to get access

Excerpt

The article [Consensus on the secondary prevention of primary liver cancer], written by [Yuemin Nan, Xiaoyuan Xu, Yanhang Gao, Rongqi Wang, Wengang Li, Ming Yang, Lingdi Liu,Zhongping Duan, Jidong Jia, Lai Wei, Hui Zhuang, Chinese Society of Hepatology, Chinese Medical Association], was originally published Online First without Open Access. After publication in volume [15], issue [6], page [1289–1300] the author decided to opt for Open Choice and to make the article an Open Access publication. Therefore, the copyright of the article has been changed to © [The Author(s)] [2021] and the article is forthwith distributed under the terms of the Creative Commons Attribution [This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. …
Metadata
Title
Correction to: Consensus on the secondary prevention of primary liver cancer
Authors
Yuemin Nan
Xiaoyuan Xu
Yanhang Gao
Rongqi Wang
Wengang Li
Ming Yang
Lingdi Liu
Zhongping Duan
Jidong Jia
Lai Wei
Hui Zhuang
Chinese Society of Hepatology, Chinese Medical Association
Publication date
01-04-2022
Publisher
Springer India
Published in
Hepatology International / Issue 2/2022
Print ISSN: 1936-0533
Electronic ISSN: 1936-0541
DOI
https://doi.org/10.1007/s12072-021-10288-2

Other articles of this Issue 2/2022

Hepatology International 2/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.